OptiBiotix Health PLC (LON:OPTI) said it was mulling a stock market listing on NASDAQ as it provided revenue guidance for its last financial year and said it hoped to reach profitability in 2020. It has tasked adviser goetzpartners securities to assess the potential of a dual UK-US quote. “Given high investor and consumer interest in the microbiome in the USA and growing sales the board OptiBiotix has commissioned advisors to explore the potential of a dual NASDAQ listing,” said chief executive Stephen O’Hara.

Ncondezi Energy Ltd (LON:NCCL) has told investors that it expects to finalise power tariff negotiations in the first half of 2020  for the integrated Ncondezi coal-fired power project and coal mine in Tete, Mozambique. “The process to finalise a tariff offer for submission to EDM is well underway and on track for submission in Q1 2020,” said Hanno Pengilly, Ncondezi’s chief executive in a statement. “The company continues to work closely with its strategic partners and tariff financial advisor to achieve a competitive firm tariff offer in line with the latest agreed tariff rates in Mozambique,” he added.

Live Company Group PLC (LON:LVCG) is targeting an expansion of its BRICKLIVE brand in 2020 as it kicked off the year with higher contracted revenues. The media firm said in a trading update for the year ended 31 December that it has secured £3mln in recognised revenues for the coming year, over 50% higher than 2019, while it is also aiming to build up to 16 BRICKLIVE themed tours before the end of 2020.

Itaconix PLC (LON:ITX) and Nouryon have agreed to terminate their agreement for Nouryon to exclusively distribute Itaconix polymers with chelating properties worldwide for detergent applications. The parties signed a supply agreement in January 2019 after conducting encouraging joint technical assessments of Itaconix’s polymers in detergent applications. An initial marketing trial by Nouryon indicated, however, that the agreement was not mutually attractive for accessing available customer opportunities, Itaconix said.

Arix Bioscience PLC’s (LON:ARIX) portfolio firm, Iterum, has announced a US$52mln private placement with new and existing investors. Arix has agreed to invest US$1.9mln in the financing round in addition to its existing stake of 7.3% in Iterum, which is valued at US$4.9mln as of close of business on 16 January.

Landore Resources Limited (LON:LND) has appointed Glenn Featherby as a non-executive director with immediate effect. The group pointed out that Featherby has over 35 years’ experience in corporate advisory work, and an extensive background in the resources sector, having begun his career with KPMG in Perth and London, prior to establishing his own accounting practice in Perth in 1997. It noted that he has previously served as a non-executive director of Patagonia Gold PLC and as non-executive chairman of Forte Energy NL.

Futura Medical PLC (LON:FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal Dermasys drug delivery technology and focused on sexual health and pain, announced that, at its General Meeting held on Friday, all resolutions were duly passed by shareholders.

Crossword Cybersecurity PLC (LON:CCS), the technology commercialisation company focused solely on cybersecurity and risk, said it has received a notice exercising options to acquire 13,333 ordinary shares in the company at a price of 280p each.

Tally will be holding its third live shareholder Q&A with its two co-founders, Cameron Parry and Ralph Hazell on the online Tally Community on Thursday 23rd January 7pm-8pm.